MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price fell 11.1% on Friday . The stock traded as low as C$0.08 and last traded at C$0.08. Approximately 471,385 shares traded hands during trading, an increase of 108% from the average session volume of 226,884 shares. The stock had previously closed at C$0.09.
MediPharm Labs Trading Down 11.1%
The company has a quick ratio of 3.10, a current ratio of 3.02 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of C$33.99 million, a P/E ratio of -4.00 and a beta of -0.53. The stock’s 50 day moving average price is C$0.08 and its 200-day moving average price is C$0.07.
MediPharm Labs Company Profile
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Read More
- Five stocks we like better than MediPharm Labs
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
